1. Barinov V.V., Zhordania K.I., Payanidi Yu.G. et al. Feasibility of using terlipressin (Remestyp) in the management of hemorrhage in surgical treatment in gynecologic oncology (ovarian cancer and cervical cancer). Onkoginekologiya, 2014, no. 1, pp. 73-77. (In Russ.)
2. Bryunnler T., Mandraka F., Langgartner Yu. Terlipressin: clinical use, rational dosing, comparison of efficacy of various dosing regimens. Clinic of University of Regensburg, Germany. Intensivmedzin und Notfallmedizin,2005, vol. 42, no. 5. Available: https://docviewer.yandex.ru/view
3. Bondar T.P., Muratova А.Yu., Shatalova G.Yu. Consistent patterns of hemostasis in the system of Mother – Child in case of noncomplicated pregnancy and trombophilia. Vestn. Stavropolskogo Gosudarstvennogo Universiteta, 2010, no. 4, pp. 187-195. (In Russ.)
4. Dron A.N. Physiological changes in hemostasis in different life time periods. Meditsinskaya Nauka i Obrazovanie Urala,2012, vol. 13, no. 2-3, pp. 123-127. (In Russ.)
5. Eralina S.N., Ismailov E.L. Intensivnaya terapiya v akusherstve. [Intensive care in obstetrics]. Monografiya. Almaty, 2017, 264 p.